GPT Healthcare Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
GPTHEALTH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
GPT Healthcare reported revenue from operations of ₹47,254.70 lakhs for FY2026, up 16.1% from ₹40,709.14 lakhs in FY2025. However, profit after tax declined 14.4% to ₹4,272.05 lakhs from ₹4,992.17 lakhs, primarily due to near-doubling of finance costs to ₹824.04 lakhs and higher depreciation of ₹2,708.83 lakhs. EPS dropped to ₹5.15 from ₹6.08. The company recommended a final dividend of 15% (₹1.50 per share), with total dividend of ₹2.50 per share including interim. Statutory auditors S R Batliboi & Co LLP issued an unmodified (clean) opinion. The board also approved related party remuneration increases for Dr. Mridul Tantia and Dr. Niharika Tantia, both relatives of directors.
PAT decline despite revenue growth signals margin compression, likely due to higher finance and depreciation costs from expansion. The clean audit and positive operating cash flow of ₹8,116.10 lakhs provide some comfort, but investors will watch for whether profitability recovers as new facilities mature.